Multifunctional Inhibitors of Cholinesterases for the Therapy of Alzheimer’s Disease (A Review)

被引：0
作者：
G. F. Makhaeva
S. O. Bachurin
机构：
[1] Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry,
[2] Russian Academy of Sciences,undefined
来源：
Russian Journal of General Chemistry | 2023年 / 93卷
关键词：
tacrine; amiridine; acetylcholinesterase; butyrylcholinesterase; beta-amyloid; antioxidants; Alzheimer’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S528 / S549
相关论文
共 50 条
  • [21] Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
    Ezio Giacobini
    [J]. Neurochemical Research, 2003, 28 : 515 - 522
  • [22] Design, synthesis and evaluation of novel tacrine coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease
    Xie, Sai-Sai
    Wang, Xiao-Bing
    Li, Jiang-Yan
    Yang, Lei
    Kong, Ling-Yi
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 : 540 - 553
  • [23] Progress in acetylcholinesterase inhibitors for Alzheimer's disease
    Bolognesi, Maria Laura
    Minarini, Anna
    Tumiatti, Vincenzo
    Melchiorre, Carlo
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (06) : 811 - 823
  • [24] Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease
    Velueta-Viveros, Martha
    Martinez-Bailen, Macarena
    Puerta, Adrian
    Romero-Hernandez, Laura L.
    Kren, Vladimir
    Merino-Montiel, Penelope
    Montiel-Smith, Sara
    Fernandes, Miguel X.
    Moreno-Vargas, Antonio J.
    Padron, Jose M.
    Lopez, Oscar
    Fernandez-Bolanos, Jose G.
    [J]. BIOORGANIC CHEMISTRY, 2022, 127
  • [25] CHOLINESTERASES AND THE PATHOLOGY OF ALZHEIMER-DISEASE
    GEULA, C
    MESULAM, MM
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1995, 9 : 23 - 28
  • [26] Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase
    AlFadly, Ehab D.
    Elzahhar, Perihan A.
    Tramarin, Anna
    Elkazaz, Salwa
    Shaltout, Hossam
    Abu-Serie, Marwa M.
    Janockova, Jana
    Soukup, Ondrej
    Ghareeb, Doaa A.
    El-Yazbi, Ahmed F.
    Rafeh, Rim W.
    Bakkar, Nour-Mounira Z.
    Kobeissy, Firas
    Iriepa, Isabel
    Moraleda, Ignacio
    Saudi, Manal N. S.
    Bartolini, Manuela
    Belal, Ahmed S. F.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 167 : 161 - 186
  • [27] Sulfonamides as multifunctional agents for Alzheimer's disease
    Bag, Seema
    Tulsan, Rekha
    Sood, Abha
    Cho, Hyejin
    Redjeb, Hana
    Zhou, Weihong
    LeVine, Harry, III
    Toeroek, Bela
    Toeroek, Marianna
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 626 - 630
  • [28] It All Starts at the Ends: Multifaceted Involvement of C- and N-Terminally Modified Cholinesterases in Alzheimer's Disease
    Berson, Amit
    Soreq, Hermona
    [J]. RAMBAM MAIMONIDES MEDICAL JOURNAL, 2010, 1 (02):
  • [29] Discovery of potent and selective dual cholinesterases and ?-secretase inhibitors in pomegranate as a treatment for Alzheimer?s disease
    Ali, Md. Yousof
    Zaib, Sumera
    Jannat, Susoma
    Khan, Imtiaz
    [J]. BIOORGANIC CHEMISTRY, 2022, 129
  • [30] A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
    Zhao, Dongju
    Tang, Yuqing
    Suo, Xinjun
    Zhang, Chaonan
    Dou, Yan
    Chang, Jin
    [J]. INNOVATION, 2021, 2 (04):
12345